Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies
- 29 June 2010
- journal article
- review article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 25 (7) , 439-448
Abstract
Chronic atrophic gastritis (CAG) is an important precursor lesion of intestinal gastric cancer. As it is typically asymptomatic, epidemiological data on the incidence of CAG are sparse. We aimed to provide an overview of published data on CAG incidence (overall and according to risk factors) from follow-up studies. Articles with information on incidence of CAG published in English until 26th of July 2009 were identified through a systematic MEDLINE and EMBASE search. Data extracted include study characteristics and key findings regarding the incidence of CAG. A meta-analysis was performed on the association between Helicobacter pylori infection and CAG incidence. Overall, data on CAG incidence were available from 14 studies, in 7 studies incidence could be estimated according to H. pylori infection. Most studies were conducted in symptomatic or high risk populations and the maximum number of incident cases was 284. Incidence estimates ranged from 0 to 11% per year and were consistently below 1% in patients not infected with H. pylori. The highest incidence was observed in a special study conducted on ulcer patients treated by proximal gastric vagotomy. Rate ratios for the association between H. pylori infection and CAG incidence ranged from 2.4 to 7.6 with a summary estimate of 5.0 (95% confidence interval: 3.1–8.3). Incidence of CAG is very low in the absence of H. pylori infection. There is a need for more population-based studies to provide comparable estimates of incidence and the impact of risk factors in the development of CAG.Keywords
This publication has 32 references indexed in Scilit:
- Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomachWorld Journal of Gastroenterology, 2009
- Immune response toHelicobacter pyloriand its association with the dynamics of chronic gastritis in the antrum and corpusAPMIS, 2008
- Epidemiology of chronic atrophic gastritis: population‐based study among 9444 older adults from GermanyAlimentary Pharmacology & Therapeutics, 2007
- Prevalence of Chronic Atrophic Gastritis in Different Parts of the WorldCancer Epidemiology, Biomarkers & Prevention, 2006
- Changes of gastric mucosal architecture during long‐term omeprazole therapy: results of a randomized clinical trialAlimentary Pharmacology & Therapeutics, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- How Helicobacter pylori urease may affect external pH and influence growth and motility in the mucus environmentEuropean Journal of Gastroenterology & Hepatology, 2003
- Does Acid Suppression by Antacids and H2 Receptor Antagonists Increase the Incidence of Atrophic Gastritis in Patients With or Without H. pylori Gastritis?Journal of Clinical Gastroenterology, 1999
- Long-Term Course and Consequences ofHelicobacter pylorigastritis Results of a 32-Year Follow-up StudyScandinavian Journal of Gastroenterology, 1996
- The Combination of Estimates from Different ExperimentsBiometrics, 1954